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INTRODUCTION 
At a recent international nephrology meeting in Bologna. one 
of the editors of this journal (E.A.F.) asked the other participants 
for documentation of successful cadaveric renal transplantation 
in type I diahetic patients treated 10 years or longer. ago. There 
\\.ere few responses. since, before this time. general appreciation 
that such patients could be treated effectively with cadaveric 
transplantation had not yet been awakened by the important stud-
ies of 1"ajarian and his associates at the University of Minnesota. 
The request was made by E.A.F. that brief reports of these un-
usual lO·year survlvors be submined. 
CASERE?ORT 
A 29-year-old wife of a physician had had type I diabetes melli-
:us since age 10. She developed renal failure in February 1971. 
:Jnd • ... ·as ac:>ted with hem~ialvsis for 11 months before trans-
;-'"m3rion. Her in~uljn require~ents we;-e 15 units Lente,·day. 
ol<;ually suP?Ic:memed with 0-15 unitsiday regular.insulin accord-
ing to need. She deye\oped visual difficulties from retinal hemor-
rhages and retinopathy at age 28. and during the II-month period 
of pre-transplantation dialysis. she became permanently blind in 
the ril!ht eve from intraocular hemorrha2e durim! dialvsis. Her 
gener~l cE1~dition rapidly deteriorated. requiring ~most continu-
ous hospitalization. Peripheral neuropathy waS very severe. with 
hilateral footdrop and bilateral anesthesia below the knees. 
Cadaveric renallransplantation was carried out on March 9. 
1972. under therapy with cyclophosphamide, prednisone and 
anti-lymphocyte globulin (ALG). Several months later the cy-
clophosphamide was changed to azathioprine. The donor was a 
19-year-old Caucasian female. Tissue matching was random. and 
there were n(1 ami2en matches at the HLA-A and B loci. Conva-
le~cence wa~ ext~mely difficult because of pre -existing disabil-
ity, and because of problems with glucose control. Mild rejection 
was diagnosed at 5 weeks and easily reversed. The neuropathy 
, .. :~ .-'- .- ... :.r-.-· 
slowly improvep., and after 2 y~Ds 'she couIdstOp,wearlng piano 
wire foot and leg braces. Daily prednisone was'weaDed to 20 mg 
by 1 year, and her present dose is 15;:Ptg/day. Azathioprine dose 
is 75 mg/day. Current daily insuliIi tequirem~nts are_20 units 
Lente. supplemented with 16-26 units ofregulirinsulin. 
Almost 11 years after transplantation her BUN is 11 mg%, 
~erum creatinine 0.7 mg%, and creatinine clearance 75 ml/min. 
Urinalysis shows no protein or other abnonnalities. 
Postoperatively, her environment was structured to allow her 
to function within the home and elsewhere despite partial blind-
ness. Cataract extraction from the left eye was perfonned 6 mon-
ths after transplantation. Because offailing vision of the "good" 
left eye. total vitrectomy was perfonned in May 1979. Enough 
vision was restored to permit perfonnance of simple tasks. A 
second "itrectomy was perfonned in· September, 1980. Subse-
quently. ~he has had glaucoma (treated with laser). She is now 
legally blind. bULstill has light perception. 
The ;:::atitnt is a vital and highly motivated person who partici-
~ates in a number of communitv functions. including the affairs 
~f the American Diabetes Ass~iation and the National Kidney 
Foundation. 
SUMMARY 
A partially blind diabetic woman who received a cadaveric kid-
nev more than ten years a2:O obtained worth-while rehabilitation 
as the result of continuous-excellent function of her graft. 
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